Search

everythinglearnresearchcommunity

for

Search:↓

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Tectona grandis leaf extracts, especially with propylene glycol, may be promising for topical hair loss treatments.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Upadacitinib effectively treated severe hair loss in a child.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

PRP shows promise for eye disease in animals but needs more research before being standard care.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

Microneedle patches with alpha-arbutin and resveratrol can effectively reduce skin pigmentation without irritation.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

The new hair loss treatment kit was safe and improved hair growth without any adverse effects.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Atrazine causes birth defects in rats, and finasteride can reliably create a hypospadias model.

Nanoemulgel is a better way to deliver drugs through the skin for various conditions.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Reticular erythematous mucinosis syndrome can occur with minimal mucin deposition.

Diphenylcyclopropenone topical immunotherapy is effective for treating alopecia areata, with some side effects.

Pityriasis rubra pilaris significantly worsens quality of life more than many other health conditions.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.